title: Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia.
abstract: The 10.1.2 MoAb reacts with a novel alpha chain that associates with the beta 1 integrin chain and is widely distributed among epithelial and endothelial cells of human adult and fetal tissues. In the epidermis and in other squamous epithelia, alpha 10.1.2 chains are expressed exclusively in the basal cell layer. Here we describe the immunohistochemical localization of alpha 10.1.2 in human epidermis, in other squamous epithelia, as well as in cultured keratinocytes. alpha 10.1.2 chain localization has also been investigated in a variety of non-neoplastic and neoplastic lesions of the skin, the uterine cervix, and the lung. We show that alpha 10.1.2 chains retain their basal keratinocyte localization in hyperplastic skin diseases and in benign tumors of the epidermis and that they are strongly expressed in basal cell carcinomas. In contrast, alpha 10.1.2 expression is decreased in keratinocytes that differentiate in vitro and is lost in epidermal dysplastic conditions, in the invading front of squamous cell carcinomas of the epidermis, in microinvasive cervical cancers, and in well-differentiated squamous lung tumors. These findings indicate that alpha 10.1.2 beta 1 integrin is downregulated during keratinocyte differentiation in vitro and in vivo. Moreover, lack of alpha 10.1.2 expression in basal cells of squamous epithelia is associated with early dysplastic changes and with the acquisition of invasive capacity.
authors.affiliation: Department of Dermatology, IRCCS University of Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Cerri
authors.forename: A
authors.initials: A
authors.lastname: Favre
authors.forename: M
authors.initials: M
authors.lastname: Giunta
authors.forename: G
authors.initials: G
authors.lastname: Corte
authors.forename: C E
authors.initials: CE
authors.lastname: Grossi
authors.forename: E
authors.initials: E
authors.lastname: Berti
mesh_terms: D000911:Antibodies, Monoclonal / Q000032:analysis / Q000276:immunology; D001706:Biopsy; D002280:Basal Cell Carcinoma / Q000737:chemistry* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000737:chemistry* / Q000473:pathology; D002454:Cell Differentiation; D002455:Cell Division; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D002478:Cells, Cultured; D004847:Epithelial Cells; D004848:Epithelium / Q000737:chemistry / Q000196:embryology; D005260:Female; D005333:Fetus / Q000473:pathology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007150:Immunohistochemistry; D019012:Integrin beta1; D016023:Integrins / Q000032:analysis* / Q000276:immunology; D015603:Keratinocytes / Q000737:chemistry / Q000473:pathology; D007636:Keratoacanthoma / Q000473:pathology; D007642:Keratosis / Q000473:pathology; D007889:Leiomyoma / Q000737:chemistry / Q000473:pathology; D008175:Lung Neoplasms / Q000737:chemistry / Q000473:pathology; D016253:Microscopy, Immunoelectron; D012867:Skin / Q000737:chemistry* / Q000166:cytology* / Q000196:embryology; D012871:Skin Diseases / Q000473:pathology; D012878:Skin Neoplasms / Q000737:chemistry* / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000737:chemistry / Q000473:pathology; D014594:Uterine Neoplasms / Q000737:chemistry / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D019012:Integrin beta1; D016023:Integrins